The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era.

Quraishi, Mohammed Nabil; Shabir, Sahida; Manzoor, Susan E; Green, Christopher A; Sharma, Naveen; Beggs, Andrew D; Iqbal, Tariq H

Quraishi, Mohammed Nabil; Shabir, Sahida; Manzoor, Susan E; Green, Christopher A; Sharma, Naveen; Beggs, Andrew D; Iqbal, Tariq H.

Quraishi MN; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.
Shabir S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Manzoor SE; Institute of Cancer and Genomic Sciences, University of Birmingham, UK.
Green CA; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.
Sharma N; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.
Beggs AD; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.
Iqbal TH; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Lancet Microbe ; 2(4): e133-e134, 2021 04.

Article in English | MEDLINE | ID: covidwho-1091548

Subject(s)

COVID-19; Colitis, Ulcerative; Fecal Microbiota Transplantation; Feces; Humans; United Kingdom/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Colitis, Ulcerative / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Microbe Year: 2021 Document Type: Article Affiliation country: S2666-5247(21)00036-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google